Revenue

A Tennessee company's patented 1-to-1 CBD and CBDA formula shows promise in fighting inflammation, setting the stage for a new class of FDA-regulated drugs.

A new alliance aims to replace painful biopsies with high-res biology, mapping organ rejection at the cellular level to usher in a new era of personalized care.

New IoT solution from Clarios prevents costly trailer failures and protects cold chain goods by providing real-time battery health insights.

Global insurer Starr commits to a 275,000 sq ft headquarters in BXP's new sustainable tower, a major vote of confidence in Midtown Manhattan's future.

The newly formed food tech giant will outline its strategic priorities, with investors closely watching for synergy updates and future growth plans.

Tidewater Midstream solidifies its position in Alberta with new five-year agreements, promising stable revenue and high utilization at its key Brazeau River facility.

Anterix hires a new product chief and sees its COO depart, signaling a major pivot from spectrum provider to a full-service solutions leader for utilities.

Southeast Asian legal tech innovators are targeting the lucrative U.S. market, but face a minefield of IP risks. Here's how they're preparing to win.

Australian CRO Avance Clinical buys U.S. specialist LumaBridge, creating a global center of excellence to accelerate cancer therapies for biotech firms.

Apogee Enterprises taps a veteran insider as interim CFO after Matthew Osberg's exit coincides with a sharp stock drop and reduced financial guidance.

Pharma giant Bayer partners with AI innovator Cradle, betting on generative AI to accelerate its biologics pipeline and reshape modern medicine.

With positive Phase 2 results for its antibody AP-101, AL-S Pharma targets a key protein in both genetic and sporadic forms of ALS, offering new hope.

New data from a major Swedish study reveals SAGA Diagnostics' Pathlight test can predict colorectal cancer recurrence with remarkable accuracy, changing the game.

A new blood test in Western Canada promises to detect 59 cancers early. But with a high price tag and pending approval, it raises critical questions.

The MTA's major investment in Wabtec's hybrid locomotives promises cleaner air for New York, safer work for crews, and a more reliable subway system.

A new universal operating system and app store, QwikOS, launches to standardize humanoid robots, making them more accessible to developers and users.

National Bank Holdings Corp. finalizes its acquisition of Vista Bank, creating a $12.6B regional power and expanding into high-growth Texas and Florida markets.

As millions of solar panels near retirement, a Nevada facility gets the final go-ahead to turn a looming waste crisis into a source of valuable materials.

China's EngineAI unveils its powerful T800 humanoid at CES 2026, backed by massive funding and signaling a new era in the global robotics race.

Following record financial growth, RadNet promotes four executives to accelerate its shift toward proactive, AI-driven healthcare and expand its market dominance.